Development of objective analysis of radiation dermatitis
Not Applicable
Recruiting
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000028602
- Lead Sponsor
- Kyoto Prefectural University of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
nothing particular
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method objective and quatitative analysis of dermatitis after breast-conserving therapy
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie radiation dermatitis in breast cancer patients as studied in JPRN-UMIN000028602?
How does JPRN-UMIN000028602's objective analysis compare to standard-of-care assessments for radiation dermatitis in breast cancer?
Which biomarkers are evaluated in JPRN-UMIN000028602 to predict radiation dermatitis outcomes in breast cancer patients?
What adverse events are associated with radiation dermatitis monitoring techniques in JPRN-UMIN000028602 breast cancer study?
Are there alternative non-invasive imaging technologies for radiation dermatitis assessment compared to JPRN-UMIN000028602's approach?